by Kaitlyn Chana
Stem cells can be used to fight diseases or replace cells damaged by things like chemotherapy. The Food and Drug Administration has cleared the way for Mayo Clinic to create larger batches of stem cells. The process by which they’re doing that is through an automated bioreactor-based stem cell production platform. Dr. Guojun Bu, associate Director of the Center for Regenerative Medicine on Mayo Clinic’s Florida campus, said a stem cell has unlimited potential to make billions of cells. “We can further push a cell to become any type of cell in your body. We can push it into any tissue or cell type in your body,” Bu said.
Context: The research of Guojun Bu, Ph.D., is centered on understanding why a specific allele of the apolipoprotein E gene (e4) represents a strong risk factor for Alzheimer's disease. Dr. Bu's Neurobiology of Alzheimer's Disease Laboratory focuses on dissecting the biological and pathological functions of the apolipoprotein E gene (APOE) and APOE receptors with particular emphasis on their roles in the pathogenesis of Alzheimer's disease and related dementias. You can read more about his research here and hear more about about work in Dr. Bu's lab in this Mayo Clinic Radio Minute.
Contact: Paul Scotti